As cell, gene and RNA therapies progress into later stages of development, teams face increasing difficulty assembling consistent, traceable evidence from diverse data sources to support timely program decisions. Multimodal data generated across assays, sites and platforms are frequently fragmented, forcing teams to rely on manual integration and limiting confidence in governance updates and regulatory narratives. This webinar examines how a measurable evidence approach can replace disconnected workflows and support decision-making at scale.

Watch this webinar to learn how cell, gene and RNA therapies teams can operationalize multimodal evidence to improve decision velocity, traceability and governance readiness.